Invention Grant
![3,4-dihydro-benzo[e][1,3]oxazin-2-ones](/docs/US/2010-09-14/US07795251B2/abs.jpg.600x600.jpg)
- Patent Title: 3,4-dihydro-benzo[e][1,3]oxazin-2-ones
- Patent Title (中): 3,4-二氢 - 苯并[e] [1,3]恶嗪-2-酮
-
Application No.: US11911154Application Date: 2006-04-13
-
Publication No.: US07795251B2Publication Date: 2010-09-14
- Inventor: Andreas Billich , Hubert Gstach , Philipp Lehr
- Applicant: Andreas Billich , Hubert Gstach , Philipp Lehr
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent John Alexander
- Priority: GB0507695.5 20050415
- International Application: PCT/EP2006/003445 WO 20060413
- International Announcement: WO2006/108671 WO 20061019
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D265/12 ; C07D498/00
![3,4-dihydro-benzo[e][1,3]oxazin-2-ones](/abs-image/US/2010/09/14/US07795251B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates 3,4-dihydro-benzo[e][1,3]oxazin-2-ones which are substituted at the nitrogen atom by unsubstituted or substituted (C1-8)alkyl, (C3-8)cycloalkyl, (C3-8)cycloalkyl(C1-4)alkyl, (C6-18)aryl or (C6-18)aryl(C1-4)alkyl and their use as pharmaceuticals.
Public/Granted literature
- US20090156588A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES Public/Granted day:2009-06-18
Information query
